Ireland bioprocessing institute features new bioreactor for training

By The Science Advisory Board staff writers

May 19, 2021 -- The National Institute of Bioprocessing Research and Training (NIBRT) in Ireland and Univercells Technologies are collaborating to address the need for training in cell and gene therapies (CGT) with installation of new equipment at NIBRT's Dublin facility.

Univercells' intermediate-capacity scale-X carbo system, featuring a fixed-bed bioreactor and in-line concentration, will be installed to provide hands-on demonstration and training to support continued education and workforce sustainability. The bioreactor will help train up workers from basic to expert-level biopharmaceutical professionals, according to the firms.

This effort is in response to the rapid growth of cell and gene therapy, which requires complex manufacturing processes that has created a shortage of highly skilled CGT manufacturing staff.

NIBRT will employ the fully operational scale-X carbo bioreactor for dedicated cell culture and viral manufacturing training courses for academia and industry experts beginning in the third quarter of 2021.

Exothera adds continuous upstream bioprocessing tech to services
Contract development and manufacturing organization Exothera has acquired the NevoLine Upstream manufacturing platform, the latest equipment available...
Exyte, Univercells fast track construction for COVID-19 vaccines
High-tech construction firm Exyte and biomanufacturing company Univercells Technologies are partnering for construction of modular standardized and flexible...
Exothera offers process development, viral vector support to biomanufacturers
Biomanufacturing company Univercells announced on March 19 that it has established a contract development and manufacturing organization named Exothera...

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter